Identification of signalling cascades involved in red blood cell shrinkage and vesiculation

Bioscience Reports

Volumn 35, Issue , 2015, Pages

  Kostova, Elena B ^a   Beuger, Boukje M ^a   Klei, Thomas R L ^a   Halonen, Pasi ^b   Lieftink, Cor ^b   Beijersbergen, Roderick ^b   Van Den Berg, Timo K ^a   Van Bruggen, Robin ^a  

^a SANQUIN RESEARCH   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Bioactive small molecule; Compound screen; Kinase inhibitor; Red blood cell; Vesiculation

Indexed keywords

5 CHLORO 4 [[2 (ISOPROPYLSULFONYL)PHENYL]AMINO] 2 [[2 METHOXY 4 [4 (4 METHYL 1 PIPERAZINYL) 1 PIPERIDINYL]PHENYL]AMINO]PYRIMIDINE; 5 [5 (4 FLUORO 2 HYDROXYPHENYL)FURFURYLIDENE] 2,4 THIAZOLIDINEDIONE; 6,7 DIHYDRO 4 HYDROXY 3 (2' HYDROXY 1,1' BIPHENYL 4 YL) 6 OXOTHIENO[2,3 B]PYRIDINE 5 CARBONITRILE; ANAPLASTIC LYMPHOMA KINASE; AS 25245; BROMOACETYLALPRENOLOLMENTHANE; CALCIUM ACTIVATED POTASSIUM CHANNEL; CALMODULIN; CASEIN KINASE II; CIBACRON BLUE F3GA; DORAMAPIMOD; EDELFOSINE; G PROTEIN COUPLED RECEPTOR; IONOMYCIN; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PONATINIB; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN SERINE THREONINE KINASE INHIBITOR; RAF PROTEIN; ROTTLERIN; SILMITASERTIB; SORAFENIB; STAT PROTEIN; TAMOXIFEN CITRATE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN RECEPTOR 2; CALCIUM IONOPHORE;

ARTICLE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL SIZE; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ERYTHROCYTE; ERYTHROCYTE VOLUME; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; NORMAL HUMAN; SIGNAL TRANSDUCTION; CELL AGING; CYTOLOGY; DRUG EFFECTS; MEMBRANE MICROPARTICLE; METABOLISM;

CALCIUM IONOPHORES; CASEIN KINASE II; CELL AGING; CELL-DERIVED MICROPARTICLES; ERYTHROCYTES; HUMANS; IONOMYCIN; RAF KINASES;

EID: 84927916647     PISSN: 01448463     EISSN: 15734935     Source Type: Journal    
DOI: 10.1042/BSR20150019     Document Type: Article

References (108)

1. Burger, P., Korsten, H., de, K.D., Rombout, E., van, B.R. and Verhoeven, A.J. (2010) An improved red blood cell additive solution maintains 2, 3-diphosphoglycerate and adenosine triphosphate levels by an enhancing effect on phosphofructokinase activity during cold storage. Transfusion 50, 2386-2392 CrossRef PubMed
2. Jy, W., Ricci, M., Shariatmadar, S., Gomez-Marin, O., Horstman, L.H. and Ahn, Y.S. (2011) Microparticles in stored red blood cells as potential mediators of transfusion complications. Transfusion 51, 886-893 CrossRef PubMed
3. Luten, M., Roerdinkholder-Stoelwinder, B., Schaap, N.P., de Grip, W.J., Bos, H.J. and Bosman, G.J. (2008) Survival of red blood cells after transfusion: a comparison between red cells concentrates of different storage periods. Transfusion 48, 1478-1485 CrossRef PubMed
4. Bosman, G.J. (2013) Survival of red blood cells after transfusion: processes and consequences. Front. Physiol. 4, 376 CrossRef PubMed
5. Kim-Shapiro, D.B., Lee, J. and Gladwin, M.T. (2011) Storage lesion: role of red blood cell breakdown. Transfusion 51, 844-851 CrossRef PubMed
6. Burger, P., Kostova, E., Bloem, E., Hilarius-Stokman, P., Meijer, A.B., van den Berg, T.K., Verhoeven, A.J., de, K.D. and van, B.R. (2013) Potassium leakage primes stored erythrocytes for phosphatidylserine exposure and shedding of pro-coagulant vesicles. Br. J. Haematol. 160, 377-386 CrossRef PubMed
7. Van Der Meijden, P.E., Van, S.M., Van, O.R., Renne, T., ten, C.H. and Spronk, H.M. (2012) Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa. J. Thromb. Haemost. 10, 1355-1362 CrossRef PubMed
8. Rubin, O., Crettaz, D., Tissot, J.D. and Lion, N. (2010) Microparticles in stored red blood cells: submicron clotting bombs? Blood Transfus. 8 (Suppl 3), s31-s38 PubMed
9. Donadee, C., Raat, N.J., Kanias, T., Tejero, J., Lee, J.S., Kelley, E.E., Zhao, X., Liu, C., Reynolds, H., Azarov, I. et al. (2011) Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation 124, 465-476 CrossRef PubMed
10. Liu, C., Zhao, W., Christ, G.J., Gladwin, M.T. and Kim-Shapiro, D.B. (2013) Nitric oxide scavenging by red cell microparticles. Free Radic. Biol. Med. 65, 1164-1173 CrossRef PubMed
11. Liu, C., Liu, X., Janes, J., Stapley, R., Patel, R.P., Gladwin, M.T. and Kim-Shapiro, D.B. (2014) Mechanism of faster NO scavenging by older stored red blood cells. Redox. Biol. 2, 211-219 CrossRef PubMed
12. Danesh, A., Inglis, H.C., Jackman, R.P., Wu, S., Deng, X., Muench, M.O., Heitman, J.W. and Norris, P.J. (2014) Exosomes from red blood cell units bind to monocytes and induce proinflammatory cytokines, boosting T-cell responses in vitro. Blood 123, 687-696 CrossRef PubMed
13. Awojoodu, A.O., Keegan, P.M., Lane, A.R., Zhang, Y., Lynch, K.R., Platt, M.O. and Botchwey, E.A. (2014) Acid sphingomyelinase is activated in sickle cell erythrocytes and contributes to inflammatory microparticle generation in SCD. Blood 124, 1941-1950 CrossRef PubMed
14. Jilani, K., Enkel, S., Bissinger, R., Almilaji, A., Abed, M. and Lang, F. (2013) Fluoxetine induced suicidal erythrocyte death. Toxins 5, 1230-1243 CrossRef PubMed
15. Daleke, D.L. (2003) Regulation of transbilayer plasma membrane phospholipid asymmetry. J. Lipid Res. 44, 233-242 CrossRef PubMed
16. Brown, G.C. and Neher, J.J. (2012) Eaten alive! Cell death by primary phagocytosis: 'phagoptosis'. Trends Biochem. Sci. 37, 325-332 CrossRef PubMed
17. Dekkers, D.W., Comfurius, P., Schroit, A.J., Bevers, E.M. and Zwaal, R.F. (1998) Transbilayer movement of NBD-labeled phospholipids in red blood cell membranes: outward-directed transport by the multidrug resistance protein 1 (MRP1). Biochemistry 37, 14833-14837 CrossRef PubMed
18. Bevers, E.M. and Williamson, P.L. (2010) Phospholipid scramblase: an update. FEBS Lett. 584, 2724-2730 CrossRef PubMed
19. Malvezzi, M., Chalat, M., Janjusevic, R., Picollo, A., Terashima, H., Menon, A.K. and Accardi, A. (2013) Ca2+-dependent phospholipid scrambling by a reconstituted TMEM16 ion channel. Nat. Commun. 4, 2367 CrossRef PubMed
20. Yang, H., Kim, A., David, T., Palmer, D., Jin, T., Tien, J., Huang, F., Cheng, T., Coughlin, S.R., Jan, Y.N. and Jan, L.Y. (2012) TMEM16F forms a Ca2+-activated cation channel required for lipid scrambling in platelets during blood coagulation. Cell 151, 111-122 CrossRef PubMed
21. Suzuki, J., Fujii, T., Imao, T., Ishihara, K., Kuba, H. and Nagata, S. (2013) Calcium-dependent phospholipid scramblase activity of TMEM16 protein family members. J. Biol. Chem. 288, 13305-13316 CrossRef PubMed
22. Willekens, F.L., Roerdinkholder-Stoelwinder, B., Groenen-Dopp, Y.A., Bos, H.J., Bosman, G.J., van den Bos, A.G., Verkleij, A.J. and Werre, J.M. (2003) Hemoglobin loss from erythrocytes in vivo results from spleen-facilitated vesiculation. Blood 101, 747-751 CrossRef PubMed
23. Piomelli, S. and Seaman, C. (1993) Mechanism of red blood cell aging: relationship of cell density and cell age. Am. J. Hematol. 42, 46-52 CrossRef PubMed
24. Mebius, R.E. and Kraal, G. (2005) Structure and function of the spleen. Nat. Rev. Immunol. 5, 606-616 CrossRef PubMed
25. Willekens, F.L., Werre, J.M., Groenen-Dopp, Y.A., Roerdinkholder-Stoelwinder, B., de, P.B. and Bosman, G.J. (2008) Erythrocyte vesiculation: a self-protective mechanism? Br. J. Haematol. 141, 549-556 CrossRef PubMed
26. Bogdanova, A., Makhro, A., Wang, J., Lipp, P. and Kaestner, L. (2013) Calcium in red blood cells-a perilous balance. Int. J. Mol. Sci. 14, 9848-9872 CrossRef PubMed
27. Wieschhaus, A., Khan, A., Zaidi, A., Rogalin, H., Hanada, T., Liu, F., De, F.L., Brugnara, C., Rivera, A. and Chishti, A.H. (2012) Calpain-1 knockout reveals broad effects on erythrocyte deformability and physiology. Biochem. J. 448, 141-152 CrossRef PubMed
28. Klarl, B.A., Lang, P.A., Kempe, D.S., Niemoeller, O.M., Akel, A., Sobiesiak, M., Eisele, K., Podolski, M., Huber, S.M., Wieder, T. and Lang, F. (2006) Protein kinase C mediates erythrocyte "programmed cell death" following glucose depletion. Am. J. Physiol. Cell Physiol. 290, C244-C253 CrossRef PubMed
29. Hochberg, Y. and Benjamini, Y. (1990) More powerful procedures for multiple significance testing. Stat. Med. 9, 811-818 CrossRef PubMed
30. Boutros, M., Bras, L.P. and Huber, W. (2006) Analysis of cell-based RNAi screens. Genome Biol 7, R66 CrossRef PubMed
31. Dreher, K.L., Eaton, J.W., Breslawec, K.P., Berger, E., Blackshear, P.L. and White, J.G. (1980) Calcium-induced erythrocyte rigidity: the roles of cellular metabolism, hydration, and ionic balance. Am. J. Pathol. 101, 543-556 PubMed
32. Smith, S.K., Farnbach, A.R., Harris, F.M., Hawes, A.C., Jackson, L.R., Judd, A.M., Vest, R.S., Sanchez, S. and Bell, J.D. (2001) Mechanisms by which intracellular calcium induces susceptibility to secretory phospholipase A2 in human erythrocytes. J. Biol. Chem. 276, 22732-22741 CrossRef PubMed
33. Berg, C.P., Engels, I.H., Rothbart, A., Lauber, K., Renz, A., Schlosser, S.F., Schulze-Osthoff, K. and Wesselborg, S. (2001) Human mature red blood cells express caspase-3 and caspase-8, but are devoid of mitochondrial regulators of apoptosis. Cell Death Differ. 8, 1197-1206 CrossRef PubMed
34. Pauig, S.B. and Daniel, L.W. (1996) Protein kinase C inhibition by ET-18-OCH3 and related analogs. A target for cancer chemotherapy. Adv. Exp. Med. Biol. 416, 173-180 CrossRef PubMed
35. Posner, A., Raser, K.J., Hajimohammadreza, I., Yuen, P.W. and Wang, K.K. (1995) Aurintricarboxylic acid is an inhibitor of mu- and m-calpain. Biochem. Mol. Biol. Int. 36, 291-299 PubMed
36. Martinez-Pinna, R., Burillo, E., Madrigal-Matute, J., Lopez, J.A., Camafeita, E., Torres-Fonseca, M.M., Llamas-Granda, P., Egido, J., Michel, J.B., Blanco-Colio, L.M. and Martin-Ventura, J.L. (2014) Label-free proteomic analysis of red blood cell membrane fractions from abdominal aortic aneurysm patients. Proteomics Clin. Appl. 8, 626-630 CrossRef PubMed
37. Sachanonta, N., Medana, I.M., Roberts, R., Jones, M., Day, N.P., White, N.J., Ferguson, D.J., Turner, G.D. and Pongponratn, E. (2008) Host vascular endothelial growth factor is trophic for Plasmodium falciparum-infected red blood cells. Asian Pac. J. Allergy Immunol. 26, 37-45 PubMed
38. Takakuwa, Y. and Mohandas, N. (1988) Modulation of erythrocyte membrane material properties by Ca2+ and calmodulin. Implications for their role in regulation of skeletal protein interactions. J. Clin. Invest. 82, 394-400 CrossRef PubMed
39. Raess, B.U. and Vincenzi, F.F. (1980) Calmodulin activation of red blood cell (Ca2+ + Mg2+)-ATPase and its antagonism by phenothiazines. Mol. Pharmacol. 18, 253-258 PubMed
40. Gietzen, K. (1983) Comparison of the calmodulin antagonists compound 48/80 and calmidazolium. Biochem. J. 216, 611-616 PubMed
41. Maher, A.D. and Kuchel, P.W. (2003) The Gardos channel: a review of the Ca2+-activated K+ channel in human erythrocytes. Int. J. Biochem. Cell Biol. 35, 1182-1197 CrossRef PubMed
42. Del, C.B., Pellegrini, M. and Pellegrino, M. (2002) Calmodulin antagonists do not inhibit IK(Ca) channels of human erythrocytes. Biochim. Biophys. Acta 1558, 133-141 CrossRef PubMed
43. Glaser, T., Schwarz-Benmeir, N., Barnoy, S., Barak, S., Eshhar, Z. and Kosower, N.S. (1994) Calpain (Ca(2+)-dependent thiol protease) in erythrocytes of young and old individuals. Proc. Natl. Acad. Sci. U.S.A. 91, 7879-7883 CrossRef PubMed
44. Catchpoole, D.R. and Stewart, B.W. (1994) Inhibition of topoisomerase II by aurintricarboxylic acid: implications for mechanisms of apoptosis. Anticancer Res. 14, 853-856 PubMed
45. James, P., Vorherr, T., Krebs, J., Morelli, A., Castello, G., McCormick, D.J., Penniston, J.T., De, F.A. and Carafoli, E. (1989) Modulation of erythrocyte Ca2+-ATPase by selective calpain cleavage of the calmodulin-binding domain. J. Biol. Chem. 264, 8289-8296 PubMed
46. Kishimoto, A., Mikawa, K., Hashimoto, K., Yasuda, I., Tanaka, S., Tominaga, M., Kuroda, T. and Nishizuka, Y. (1989) Limited proteolysis of protein kinase C subspecies by calcium-dependent neutral protease (calpain). J. Biol. Chem. 264, 4088-4092 PubMed
47. Boivin, P., Galand, C. and Dhermy, D. (1990) In vitro digestion of spectrin, protein 4.1 and ankyrin by erythrocyte calcium dependent neutral protease (calpain I). Int. J. Biochem. 22, 1479-1489 CrossRef PubMed
48. De, F.L., Franco, R.S., Bertoldi, M., Brugnara, C., Matte, A., Siciliano, A., Wieschhaus, A.J., Chishti, A.H. and Joiner, C.H. (2013) Pharmacological inhibition of calpain-1 prevents red cell dehydration and reduces Gardos channel activity in a mouse model of sickle cell disease. FASEB J. 27, 750-759 CrossRef PubMed
49. Fox, J.E., Austin, C.D., Reynolds, C.C. and Steffen, P.K. (1991) Evidence that agonist-induced activation of calpain causes the shedding of procoagulant-containing microvesicles from the membrane of aggregating platelets. J. Biol. Chem. 266, 13289-13295 PubMed
50. Fathallah, H., Sauvage, M., Romero, J.R., Canessa, M. and Giraud, F. (1997) Effects of PKC alpha activation on Ca2+ pump and K(Ca) channel in deoxygenated sickle cells. Am. J. Physiol. 273, C1206-C1214 PubMed
51. Manno, S., Takakuwa, Y. and Mohandas, N. (2005) Modulation of erythrocyte membrane mechanical function by protein 4.1 phosphorylation. J. Biol. Chem. 280, 7581-7587 CrossRef PubMed
52. Govekar, R.B. and Zingde, S.M. (2001) Protein kinase C isoforms in human erythrocytes. Ann. Hematol. 80, 531-534 CrossRef PubMed
53. Govekar, R.B., Kawle, P.D., Advani, S.H. and Zingde, S.M. (2012) Reduced PKC alpha activity induces senescent phenotype in erythrocytes. Anemia 2012, 168050 PubMed
54. Andrews, D.A., Yang, L. and Low, P.S. (2002) Phorbol ester stimulates a protein kinase C-mediated agatoxin-TK-sensitive calcium permeability pathway in human red blood cells. Blood 100, 3392-3399 CrossRef PubMed
55. Del, C.B., Pellegrini, M. and Pellegrino, M. (2003) Modulation of Ca2+-activated K+ channels of human erythrocytes by endogenous protein kinase C. Biochim. Biophys. Acta 1612, 107-116 CrossRef PubMed
56. Cool, B., Zinker, B., Chiou, W., Kifle, L., Cao, N., Perham, M., Dickinson, R., Adler, A., Gagne, G., Iyengar, R. et al. (2006) Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab. 3, 403-416 CrossRef PubMed
57. Long, Y.C. and Zierath, J.R. (2006) AMP-activated protein kinase signaling in metabolic regulation. J. Clin. Invest 116, 1776-1783 CrossRef PubMed
58. Carling, D., Thornton, C., Woods, A. and Sanders, M.J. (2012) AMP-activated protein kinase: new regulation, new roles? Biochem. J. 445, 11-27 CrossRef PubMed
59. Foller, M., Sopjani, M., Koka, S., Gu, S., Mahmud, H., Wang, K., Floride, E., Schleicher, E., Schulz, E., Munzel, T. and Lang, F. (2009) Regulation of erythrocyte survival by AMP-activated protein kinase. FASEB J. 23, 1072-1080 CrossRef PubMed
60. Sid, B., Miranda, L., Vertommen, D., Viollet, B. and Rider, M.H. (2010) Stimulation of human and mouse erythrocyte Na(+)-K(+)-2Cl(-) cotransport by osmotic shrinkage does not involve AMP-activated protein kinase, but is associated with STE20/SPS1-related proline/alanine-rich kinase activation. J. Physiol. 588, 2315-2328 CrossRef PubMed
61. Pargellis, C., Tong, L., Churchill, L., Cirillo, P.F., Gilmore, T., Graham, A.G., Grob, P.M., Hickey, E.R., Moss, N., Pav, S. and Regan, J. (2002) Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site. Nat. Struct. Biol. 9, 268-272 CrossRef PubMed
62. Kapus, A. and Szaszi, K. (2006) Coupling between apical and paracellular transport processes. Biochem. Cell Biol. 84, 870-880 CrossRef PubMed
63. Gatidis, S., Zelenak, C., Fajol, A., Lang, E., Jilani, K., Michael, D., Qadri, S.M. and Lang, F. (2011) p38 MAPK activation and function following osmotic shock of erythrocytes. Cell Physiol. Biochem. 28, 1279-1286 CrossRef PubMed
64. Dalmas, D.A., Tierney, L.A., Zhang, C., Narayanan, P.K., Boyce, R.W., Schwartz, L.W., Frazier, K.S. and Scicchitano, M.S. (2008) Effects of p38 MAP kinase inhibitors on the differentiation and maturation of erythroid progenitors. Toxicol. Pathol. 36, 958-971 CrossRef PubMed
65. Tamura, K., Sudo, T., Senftleben, U., Dadak, A.M., Johnson, R. and Karin, M. (2000) Requirement for p38alpha in erythropoietin expression: a role for stress kinases in erythropoiesis. Cell 102, 221-231 CrossRef PubMed
66. Uddin, S., Ah-Kang, J., Ulaszek, J., Mahmud, D. and Wickrema, A. (2004) Differentiation stage-specific activation of p38 mitogen-activated protein kinase isoforms in primary human erythroid cells. Proc. Natl. Acad. Sci. U.S.A. 101, 147-152 CrossRef PubMed
67. Escudier, B. (2011) Sorafenib for the management of advanced renal cell carcinoma. Expert. Rev. Anticancer Ther. 11, 825-836 CrossRef PubMed
68. Duntas, L.H. and Bernardini, R. (2010) Sorafenib: rays of hope in thyroid cancer. Thyroid 20, 1351-1358 CrossRef PubMed
69. Abou-Alfa, G.K. and Saltz, L.B. (2011) Doxorubicin and sorafenib for treatment of advanced hepatocellular cancer. Gastroenterology 141, e19-e20 CrossRef PubMed
70. Wilhelm, S.M., Carter, C., Tang, L., Wilkie, D., McNabola, A., Rong, H., Chen, C., Zhang, X., Vincent, P., McHugh, M. et al. (2004) BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis. Cancer Res. 64, 7099-7109 CrossRef PubMed
71. Lupescu, A., Shaik, N., Jilani, K., Zelenak, C., Lang, E., Pasham, V., Zbidah, M., Plate, A., Bitzer, M., Foller, M. et al. (2012) Enhanced erythrocyte membrane exposure of phosphatidylserine following sorafenib treatment: an in vivo and in vitro study. Cell Physiol. Biochem. 30, 876-888 CrossRef PubMed
72. Mikula, M., Schreiber, M., Husak, Z., Kucerova, L., Ruth, J., Wieser, R., Zatloukal, K., Beug, H., Wagner, E.F. and Baccarini, M. (2001) Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene. EMBO J. 20, 1952-1962 CrossRef PubMed
73. Kolbus, A., Pilat, S., Husak, Z., Deiner, E.M., Stengl, G., Beug, H. and Baccarini, M. (2002) Raf-1 antagonizes erythroid differentiation by restraining caspase activation. J. Exp. Med. 196, 1347-1353 CrossRef PubMed
74. Rubiolo, C., Piazzolla, D., Meissl, K., Beug, H., Huber, J.C., Kolbus, A. and Baccarini, M. (2006) A balance between Raf-1 and Fas expression sets the pace of erythroid differentiation. Blood 108, 152-159 CrossRef PubMed
75. Hennessy, B.T., Smith, D.L., Ram, P.T., Lu, Y. and Mills, G.B. (2005) Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat. Rev. Drug Discov. 4, 988-1004 CrossRef PubMed
76. Suhr, F., Brenig, J., Muller, R., Behrens, H., Bloch, W. and Grau, M. (2012) Moderate exercise promotes human RBC-NOS activity, NO production and deformability through Akt kinase pathway. PLoS One 7, e45982 CrossRef PubMed
77. Pomel, V., Klicic, J., Covini, D., Church, D.D., Shaw, J.P., Roulin, K., Burgat-Charvillon, F., Valognes, D., Camps, M., Chabert, C. et al. (2006) Furan-2-ylmethylene thiazolidinediones as novel, potent, and selective inhibitors of phosphoinositide 3-kinase gamma. J. Med. Chem. 49, 3857-3871 CrossRef PubMed
78. Grimshaw, K.M., Hunter, L.J., Yap, T.A., Heaton, S.P., Walton, M.I., Woodhead, S.J., Fazal, L., Reule, M., Davies, T.G., Seavers, L.C. et al. (2010) AT7867 is a potent and oral inhibitor of AKT and p70 S6 kinase that induces pharmacodynamic changes and inhibits human tumor xenograft growth. Mol. Cancer Ther. 9, 1100-1110 CrossRef PubMed
79. Kaestner, L., Christophersen, P., Bernhardt, I. and Bennekou, P. (2000) The non-selective voltage-activated cation channel in the human red blood cell membrane: reconciliation between two conflicting reports and further characterisation. Bioelectrochemistry 52, 117-125 CrossRef PubMed
80. Kaestner, L., Bollensdorff, C. and Bernhardt, I. (1999) Non-selective voltage-activated cation channel in the human red blood cell membrane. Biochim. Biophys. Acta 1417, 9-15 CrossRef PubMed
81. Harrison, T., Samuel, B.U., Akompong, T., Hamm, H., Mohandas, N., Lomasney, J.W. and Haldar, K. (2003) Erythrocyte G protein-coupled receptor signaling in malarial infection. Science 301, 1734-1736 CrossRef PubMed
82. Zennadi, R., Moeller, B.J., Whalen, E.J., Batchvarova, M., Xu, K., Shan, S., Delahunty, M., Dewhirst, M.W. and Telen, M.J. (2007) Epinephrine-induced activation of LW-mediated sickle cell adhesion and vaso-occlusion in vivo. Blood 110, 2708-2717 CrossRef PubMed
83. Goldman, D., Fraser, G.M., Ellis, C.G., Sprague, R.S., Ellsworth, M.L. and Stephenson, A.H. (2012) Toward a multiscale description of microvascular flow regulation: o(2)-dependent release of ATP from human erythrocytes and the distribution of ATP in capillary networks. Front. Physiol. 3, 246 CrossRef PubMed
84. Corriden, R. and Insel, P.A. (2010) Basal release of ATP: an autocrine-paracrine mechanism for cell regulation. Sci. Signal. 3, re1 PubMed
85. Hoffman, J.F., Dodson, A., Wickrema, A. and Dib-Hajj, S.D. (2004) Tetrodotoxin-sensitive Na+ channels and muscarinic and purinergic receptors identified in human erythroid progenitor cells and red blood cell ghosts. Proc. Natl. Acad. Sci. U.S.A. 101, 12370-12374 CrossRef PubMed
86. Tanneur, V., Duranton, C., Brand, V.B., Sandu, C.D., Akkaya, C., Kasinathan, R.S., Gachet, C., Sluyter, R., Barden, J.A., Wiley, J.S. et al. (2006) Purinoceptors are involved in the induction of an osmolyte permeability in malaria-infected and oxidized human erythrocytes. FASEB J. 20, 133-135 PubMed
87. Wang, L., Olivecrona, G., Gotberg, M., Olsson, M.L., Winzell, M.S. and Erlinge, D. (2005) ADP acting on P2Y13 receptors is a negative feedback pathway for ATP release from human red blood cells. Circ. Res. 96, 189-196 CrossRef PubMed
88. Nathan, I., Dvilansky, A., Gross, M. and Korczyn, A.D. (1979) Effect of beta-blockers on sodium and potassium content of human erythrocytes. Arch. Int. Physiol. Biochim. 87, 935-941 CrossRef PubMed
89. Cicco, G., Vetrugno, M., Rotelli, M.T., Sborgia, G., Pennetta, M., Vico, P.P., Memeo, V., Nitti, L. and Sborgia, C. (2006) Red blood cell (RBC) surface acetylcholinesterase showing a hemorheological pattern during glaucoma treatment. Clin. Hemorheol. Microcirc. 35, 149-154 PubMed
90. Oonishi, T., Sakashita, K. and Uyesaka, N. (1997) Regulation of red blood cell filterability by Ca2+ influx and cAMP-mediated signaling pathways. Am. J. Physiol. 273, C1828-C1834 PubMed
91. Tuvia, S., Moses, A., Gulayev, N., Levin, S. and Korenstein, R. (1999) Beta-adrenergic agonists regulate cell membrane fluctuations of human erythrocytes. J. Physiol. 516 (Pt 3), 781-792 CrossRef PubMed
92. Oslob, J.D., Romanowski, M.J., Allen, D.A., Baskaran, S., Bui, M., Elling, R.A., Flanagan, W.M., Fung, A.D., Hanan, E.J., Harris, S. et al. (2008) Discovery of a potent and selective aurora kinase inhibitor. Bioorg. Med. Chem. Lett. 18, 4880-4884 CrossRef PubMed
93. Wu, C., Orozco, C., Boyer, J., Leglise, M., Goodale, J., Batalov, S., Hodge, C.L., Haase, J., Janes, J., Huss, III, J.W. and Su, A.I. (2009) BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol. 10, R130 CrossRef PubMed
94. Baffert, F., Regnier, C.H., De, P.A., Pissot-Soldermann, C., Tavares, G.A., Blasco, F., Brueggen, J., Chene, P., Drueckes, P., Erdmann, D. et al. (2010) Potent and selective inhibition of polycythemia by the quinoxaline JAK2 inhibitor NVP-BSK805. Mol. Cancer Ther. 9, 1945-1955 CrossRef PubMed
95. Koury, M.J., Sawyer, S.T. and Brandt, S.J. (2002) New insights into erythropoiesis. Curr. Opin. Hematol. 9, 93-100 CrossRef PubMed
96. Goodman, S.R., Kurdia, A., Ammann, L., Kakhniashvili, D. and Daescu, O. (2007) The human red blood cell proteome and interactome. Exp. Biol. Med. 232, 1391-1408 CrossRef
97. O'Hare, T., Shakespeare, W.C., Zhu, X., Eide, C.A., Rivera, V.M., Wang, F., Adrian, L.T., Zhou, T., Huang, W.S., Xu, Q. et al. (2009) AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance. Cancer Cell 16, 401-412 CrossRef PubMed
98. Slavova-Azmanova, N.S., Kucera, N., Louw, A., Satiaputra, J., Handoko, A., Singer, P., Stone, L., McCarthy, D.J., Klinken, S.P., Hibbs, M.L. and Ingley, E. (2014) Lyn kinase plays important roles in erythroid expansion, maturation and erythropoietin receptor signalling by regulating inhibitory signalling pathways that control survival. Biochem. J. 459, 455-466 CrossRef PubMed
99. Brunati, A.M., Bordin, L., Clari, G., James, P., Quadroni, M., Baritono, E., Pinna, L.A. and Donella-Deana, A. (2000) Sequential phosphorylation of protein band 3 by Syk and Lyn tyrosine kinases in intact human erythrocytes: identification of primary and secondary phosphorylation sites. Blood 96, 1550-1557 PubMed
100. De, F.L., Tomelleri, C., Matte, A., Brunati, A.M., Bovee-Geurts, P.H., Bertoldi, M., Lasonder, E., Tibaldi, E., Danek, A., Walker, R.H. et al. (2011) Erythrocyte membrane changes of chorea-acanthocytosis are the result of altered Lyn kinase activity. Blood 118, 5652-5663 CrossRef PubMed
101. Olsson, A.K., Dimberg, A., Kreuger, J. and Claesson-Welsh, L. (2006) VEGF receptor signalling - in control of vascular function. Nat. Rev. Mol. Cell Biol. 7, 359-371 CrossRef PubMed
102. Galkin, A.V., Melnick, J.S., Kim, S., Hood, T.L., Li, N., Li, L., Xia, G., Steensma, R., Chopiuk, G., Jiang, J. et al. (2007) Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK. Proc. Natl. Acad. Sci. U.S.A. 104, 270-275 CrossRef PubMed
103. Hallberg, B. and Palmer, R.H. (2013) Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology. Nat. Rev. Cancer 13, 685-700 CrossRef PubMed
104. Siddiqui-Jain, A., Drygin, D., Streiner, N., Chua, P., Pierre, F., O'Brien, S.E., Bliesath, J., Omori, M., Huser, N., Ho, C. et al. (2010) CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy. Cancer Res. 70, 10288-10298 CrossRef PubMed
105. Melhorn, M.I., Brodsky, A.S., Estanislau, J., Khoory, J.A., Illigens, B., Hamachi, I., Kurishita, Y., Fraser, A.D., Nicholson-Weller, A., Dolmatova, E. et al. (2013) CR1-mediated ATP release by human red blood cells promotes CR1 clustering and modulates the immune transfer process. J. Biol. Chem. 288, 31139-31153 CrossRef PubMed
106. Glodek, A.M., Mirchev, R., Golan, D.E., Khoory, J.A., Burns, J.M., Shevkoplyas, S.S., Nicholson-Weller, A. and Ghiran, I.C. (2010) Ligation of complement receptor 1 increases erythrocyte membrane deformability. Blood 116, 6063-6071 CrossRef PubMed
107. Bildl, W., Strassmaier, T., Thurm, H., Andersen, J., Eble, S., Oliver, D., Knipper, M., Mann, M., Schulte, U., Adelman, J.P. and Fakler, B. (2004) Protein kinase CK2 is coassembled with small conductance Ca(2+)-activated K+ channels and regulates channel gating. Neuron 43, 847-858 CrossRef PubMed
108. Adelman, J.P., Maylie, J. and Sah, P. (2012) Small-conductance Ca2+-activated K+ channels: form and function. Annu. Rev. Physiol. 74, 245-269 CrossRef PubMed